- Higher serum FGF23 independently associated with cognitive impairment and lower MMSE scores in older haemodialysis patients (OR per 1-SD increase = 5.46).
- Elevated FGF23 also independently associated with restless legs syndrome after adjustment for age and sex (OR per 1-SD = 2.31).
- Serum Klotho showed no association with cognition, depressive symptoms, insomnia severity, or RLS; results are cross-sectional and not causal.
Psychogeriatrics. 2026 Nov;26(6):e70239. doi: 10.1111/psyg.70239.
ABSTRACT
BACKGROUND: Cognitive impairment, depression, sleep disturbances and restless legs syndrome (RLS) are common among older haemodialysis patients, but the contribution of the FGF23-Klotho axis to these neuropsychiatric manifestations remains unclear. We aimed to evaluate whether serum FGF23 and Klotho concentrations are associated with these outcomes in this population.
METHODS: This prospective cross-sectional study included 89 patients aged ≥ 60 years undergoing maintenance haemodialysis. Serum FGF23 and Klotho concentrations were measured by enzyme-linked immunosorbent assay. Cognitive impairment was defined as Mini-Mental State Examination (MMSE) < 24 and depression as 30-item Geriatric Depression Scale (GDS-30) ≥ 14; insomnia severity was assessed using the Insomnia Severity Index (ISI; 0-28), and restless legs syndrome (RLS) was diagnosed according to the five essential revised International Restless Legs Syndrome Study Group (IRLSSG) criteria. Associations were evaluated using correlation and multivariable regression analyses, including Firth’s penalized regression for RLS.
RESULTS: Mean age was 71.3 ± 6.7 years; 58.4% were female. Cognitive impairment, depression and RLS were present in 52.8%, 40.4% and 13.5% of participants, respectively. Higher serum FGF23 was independently associated with cognitive impairment after adjustment for age, sex, educational attainment and dialysis vintage (OR per 1-SD increase = 5.46, 95% CI 1.18-25.36) and with RLS after adjustment for age and sex (OR per 1-SD increase = 2.31, 95% CI 1.21-4.42). These associations remained significant in sensitivity analyses. FGF23 correlated negatively with MMSE scores and remained associated with lower MMSE scores in adjusted analyses, whereas Klotho was not associated with cognitive measures. Neither biomarker was associated with depressive symptoms or insomnia severity.
CONCLUSION: Higher FGF23 levels were associated with cognitive impairment, poorer cognitive performance and RLS in older haemodialysis patients, whereas serum Klotho was not associated with any of the neuropsychiatric outcomes examined; given the cross-sectional design, these findings should be interpreted as associations rather than evidence of causality.
PMID:43006170 | DOI:10.1111/psyg.70239
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

